X

Health Care

Aurobindo Pharma Limited Q4 FY22 Earnings Conference Call Insights

https://youtu.be/ZZNGEHlRimc Key highlights from Aurobindo Pharma Limited (AUROPHARMA) Q4 FY22 Earnings Concall Management Update: AUROPHARMA received final approval for 3…

Hikal Limited Q4 FY22 Earnings Conference Call Insights

https://youtu.be/3z2q_SR1OS4 Key highlights from Hikal Limited (HIKAL) Q4 FY22 Earnings Concall Management Update: HIKAL said its new product launches in…

Hikal Limited (HIKAL) Q4 FY22 Earnings Concall Transcript

Hikal Limited (NSE: HIKAL) Q4 FY22 Earnings Concall dated Jun. 03, 2022 Corporate Participants: Anish Swadi -- Senior President of Animal Health…

Glenmark Pharmaceuticals Limited Q4 FY22 Earnings Conference Call Insights

https://youtu.be/uTUQ9VpSoiU Key highlights from Glenmark Pharmaceuticals Limited (GLENMARK) Q4 FY22 Earnings Concall Management Update: GLENMARK said the India business continues…

Piramal Enterprises Ltd Q4 FY22 Earnings Conference Call Insights

Key highlights from Piramal Enterprises Ltd (PEL) Q4 FY22 Earnings Concall Management Update: Over the next five years, PEL aspire…

Torrent Pharmaceuticals Ltd Q4 FY22 Earnings Conference Call Insights

Key highlights from Torrent Pharmaceuticals Ltd (TORNTPHARM) Q4 FY22 Earnings Concall Q&A Highlights: Anubhav Aggarwal of Credit Suisse asked about…

Supriya Lifescience Ltd Q4 FY22 Earnings Conference Call Insights

https://youtu.be/VIL70Aj2g04 Key highlights from Supriya Lifescience Ltd (SUPRIYA) Q4 FY22 Earnings Concall Management Update: SUPRIYA said that going forward the…

Divi’s Laboratories Ltd Q4 FY22 Earnings Conference Call Insights

https://youtu.be/MLu1npKFqZg Key highlights from Divi's Laboratories Ltd (DIVISLAB) Q4 FY22 Earnings Concall Management Update: DIVISLAB said it reached milestone revenue…

Dr Lal PathLabs Ltd Q4 FY22 Earnings Conference Call Insights

https://youtu.be/XGfFd6kLFCE Key highlights from Dr Lal PathLabs Ltd (LALPATHLAB) Q4 FY22 Earnings Concall Management Update: LALPATHLAB said it saw significant…

Dr Lal PathLabs Ltd (LALPATHLAB) Q4 FY22 Earnings Concall Transcript

Dr Lal PathLabs Ltd (NSE: LALPATHLAB) Q4 FY22 Earnings Concall dated May. 17, 2022 Corporate Participants: Nishid Solanki -- Arvind Lal -- Executive…